Loading...
Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis
BACKGROUND: Untreated hemophilia A patients may experience recurrent bleeding events leading to debilitating joint damages. While RCT and pharmacokinetic data support the value of Kovaltry [an unmodified full-length recombinant factor VIII (FVIII) product], real world evidence in children is lacking...
Na minha lista:
| Udgivet i: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809751/ https://ncbi.nlm.nih.gov/pubmed/33451335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01676-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|